Format

Send to

Choose Destination
J Endocrinol Invest. 2017 Jan;40(1):27-32. doi: 10.1007/s40618-016-0500-2. Epub 2016 Jun 14.

Effects of nutraceuticals on quality of life and sexual function of perimenopausal women.

Author information

1
Department of General Surgery and Medical Surgical Specialties, Gynecological Clinic of the Policlinico Universitario, Via S.Sofia 78, 95124, Catania, Italy. scaruso@unict.it.
2
Research Group for Sexology, Catania, Italy. scaruso@unict.it.
3
Department of General Surgery and Medical Surgical Specialties, Gynecological Clinic of the Policlinico Universitario, Via S.Sofia 78, 95124, Catania, Italy.
4
Research Group for Sexology, Catania, Italy.

Abstract

PURPOSE:

The aim of the study was to evaluate the effects of nutraceuticals containing Equol, Resveratrol, Quecitine and Passiflora (Zemiar®, Avantgarde, Pomezia, Rome, Italy) on quality of life (QoL) and sexual function in perimenopausal women.

METHODS:

Sixty perimenopausal women having vasomotor symptoms and being in the -1, +1a of the STRAW system (amenorrhea for longer than 60 days and FSH < 20 UI/L) were enrolled. The modified Kupperman Index (KI) was used to evaluate menopause symptoms. The Short Form-36 (SF-36), Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess QoL, sexual function and sexual distress, respectively. The study had two follow-ups at 3 and 6 months.

RESULTS:

The women reported an improvement in the KI total score from the baseline (35 ± 4) to the 1st (21 ± 3, p < 0.05) and the 2nd (18 ± 2, p < 0.01) follow-ups. At the 1st follow-up, the women reported QoL improvements in some functions (p < 0.05); at the 2nd follow-up, they reported improvements in all categories (p < 0.001). At baseline, the total FSFI score was 23.1 ± 1.2 and the FSDS score was 18.1 ± 1.4, both indicating sexual dysfunction with sexual distress. FSFI and FSDS total scores did not change at the 1st follow-up (p = NS). On the contrary, at the 2nd follow-up, the FSFI score had risen to (27.6 ± 1.5) (p < 0.001) and the FSDS score had dropped to (11.3 ± 1.2) (p < 0.001).

CONCLUSIONS:

Nutraceuticals can be effective in modulating the perimenopausal symptoms in women. The progressive reduction of the vasomotor symptoms reported by women over the nutraceutical usage could contribute to improve their QoL and sexual life.

KEYWORDS:

Nutraceuticals; Perimenopausal; Quality of Life; Sexual life; Vasomotor symptoms

PMID:
27300032
DOI:
10.1007/s40618-016-0500-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center